<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Ophthalmol</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Ophthalmol</journal-id><journal-id journal-id-type="pmc-domain-id">3211</journal-id><journal-id journal-id-type="pmc-domain">jamasd</journal-id><journal-title-group><journal-title>JAMA Ophthalmology</journal-title></journal-title-group><issn pub-type="ppub">2168-6165</issn><issn pub-type="epub">2168-6173</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>JAMA Network</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10273131</article-id><article-id pub-id-type="pmcid-ver">PMC10273131.1</article-id><article-id pub-id-type="pmcaid">10273131</article-id><article-id pub-id-type="pmcaiid">10273131</article-id><article-id pub-id-type="pmid">37318786</article-id><article-id pub-id-type="doi">10.1001/jamaophthalmol.2023.2415</article-id><article-id pub-id-type="publisher-id">eoi230034</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="domain" specific-use="print"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="online-first"><subject>Online First</subject></subj-group><subj-group subj-group-type="allowCommenting"><subject>Comments</subject></subj-group></article-categories><title-group><article-title>Social Risk Factor Associations With Presenting Visual Acuity in Patients With Microbial Keratitis</article-title><alt-title alt-title-type="headline">Social Risk Factor Associations With Presenting Visual Acuity in Patients With Microbial Keratitis</alt-title><alt-title alt-title-type="running-head">Social Risk Factor Associations With Presenting Visual Acuity in Patients With Microbial Keratitis</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Hicks</surname><given-names initials="PM">Patrice M.</given-names></name><degrees>PhD</degrees><degrees>MPH</degrees><xref rid="eoi230034aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Niziol</surname><given-names initials="LM">Leslie M.</given-names></name><degrees>MS</degrees><xref rid="eoi230034aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Newman-Casey</surname><given-names initials="PA">Paula Anne</given-names></name><degrees>MD</degrees><degrees>MS</degrees><xref rid="eoi230034aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="eoi230034aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Salami</surname><given-names initials="K">Kassim</given-names></name><degrees>BS</degrees><xref rid="eoi230034aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Singh</surname><given-names initials="K">Karandeep</given-names></name><degrees>MD</degrees><degrees>MMSc</degrees><xref rid="eoi230034aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="eoi230034aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="eoi230034aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Woodward</surname><given-names initials="MA">Maria A.</given-names></name><degrees>MD</degrees><degrees>MSc</degrees><xref rid="eoi230034aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="eoi230034aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="eoi230034aff1"><label>1</label>Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor</aff><aff id="eoi230034aff2"><label>2</label>Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor</aff><aff id="eoi230034aff3"><label>3</label>Department of Learning Health Sciences, University of Michigan Medical School, Ann Arbor</aff><aff id="eoi230034aff4"><label>4</label>Department of Internal Medicine, University of Michigan Medical School, Ann Arbor</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> April 23, 2023.</p><p content-type="published-online"><bold>Published Online:</bold> June 15, 2023. doi:<uri content-type="doi">10.1001/jamaophthalmol.2023.2415</uri></p><corresp id="eoi230034cor1"><bold>Corresponding Author:</bold> Maria A. Woodward, MD, MS, Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, 1000 Wall St, Ann Arbor, MI 48105 (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mariawoo@med.umich.edu">mariawoo@med.umich.edu</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Dr Woodward had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic toggle="yes">Concept and design:</italic> Hicks, Newman-Casey, Salami, Singh, Woodward.</p><p><italic toggle="yes">Acquisition, analysis, or interpretation of data:</italic> Hicks, Niziol, Woodward.</p><p>
<italic toggle="yes">Drafting of the manuscript: Hicks, Niziol.</italic>
</p><p><italic toggle="yes">Critical revision of the manuscript for important intellectual content:</italic> All authors.</p><p><italic toggle="yes">Statistical analysis:</italic> Niziol.</p><p><italic toggle="yes">Obtained funding:</italic> Hicks, Woodward.</p><p><italic toggle="yes">Administrative, technical, or material support:</italic> Niziol, Singh, Woodward.</p><p><italic toggle="yes">Supervision:</italic> Hicks, Newman-Casey, Woodward.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Hicks reported receiving funding from the National Institutes of Health and the National Eye Institute during the conduct of the study. Dr Newman-Casey reported receiving grants from Research to Prevent Blindness, the National Institutes of Health, the National Institute of Biomedical Imaging and Bioengineering, and the US Centers for Disease Control and Prevention outside the submitted work. Dr Singh reported receiving grants from the National Institute of Diabetes and Digestive and Kidney Diseases, Blue Cross Blue Shield of Michigan, Teva Pharmaceuticals, the National Institutes of Health, and the National Eye Institute and consultant/advisory board fees from Flatiron Health Past outside the submitted work. Dr Woodward reported receiving grants from the National Eye Institute, Research to Prevent Blindness, and Michigan Institute for Clinical and Translational Research during the conduct of the study. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Fund</bold><bold>ing/Support:</bold> This research was supported in part by grant R01EY031033, from the <funding-source rid="sp1">National Eye Institute</funding-source> (Drs Woodward and Singh); the <funding-source rid="sp2">Research to Prevent Blindness</funding-source> Career Advancement Award (Dr Woodward); grant UL1TR002240 from <funding-source rid="sp3">Michigan Institute for Clinical and Translational Research</funding-source> (Dr Woodward); a Research to Prevent Blindness Scientist Award (Dr Newman-Casey); the <funding-source rid="sp4">National Institutes of Health</funding-source> (National Eye Institute grant R01EY031337-01 [Dr Newman-Casey]); National Eye Institute grant R01EY031337-03S1 [Dr Hicks]; the <funding-source rid="sp5">National Institute of General Medical Sciences</funding-source> grant GM111725 [Dr Hicks]; the <funding-source rid="sp6">National Institute of Diabetes and Digestive and Kidney Diseases</funding-source> grant R01DK133226 [Dr Singh]); and grant R01EB032328 from the <funding-source rid="sp7">National Institute of Biomedical Imaging and Bioengineering</funding-source> (Dr Newman-Casey).</p><p><bold>Role of the Funder/Sponsor:</bold> The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-EOI230034-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p><p><bold>Additional Contributions:</bold> We thank Ms Susan Lane for her financial support of personnel involved in this research study. No financial compensation was received for contributions.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2023-06-15T10:00"><day>15</day><month>6</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>8</month><year>2023</year></pub-date><volume>141</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">438435</issue-id><fpage>727</fpage><lpage>734</lpage><history><date date-type="received"><day>15</day><month>2</month><year>2023</year></date><date date-type="accepted"><day>23</day><month>4</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>15</day><month>06</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>15</day><month>06</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 00:25:16.450"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright 2023 American Medical Association. All Rights Reserved.</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jamaophthalmol-e232415.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf-version" xlink:href="jamaophthalmol-e232415.pdf">jamaophthalmol-e232415.pdf</self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="silverchair" xlink:href="https://jamanetwork.com/journals/archopht/fullarticle/10.1001/jamaophthalmol.2023.2415"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary" xml:lang="en" journal-id="JAMA Ophthalmol" journal-id-type="nlm-ta" ext-link-type="pubmed" xlink:href="37318784"><article-title>Taking Steps to Advance Health Equity in Ophthalmology.</article-title><date><day>15</day><month>6</month><year>2023</year></date><source>JAMA Ophthalmol</source><pub-id pub-id-type="doi">10.1001/jamaophthalmol.2023.2595</pub-id><pub-id pub-id-type="pmid">37318784</pub-id></related-article><abstract abstract-type="teaser" specific-use="electronic"><p>This cross-sectional study investigates the association of neighborhood-level social risk factors with worse-presenting best-corrected visual acuity in patients with microbial keratitis infections.</p></abstract><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-eoi230034-1"><title>Question</title><p>Individual-level factors including age and race are known to be associated with severity of microbial keratitis (MK) infections, but are neighborhood-level social risk factors associated with worse-presenting best-corrected visual acuity (BCVA) in MK?</p></sec><sec id="ab-eoi230034-2"><title>Findings</title><p>In this cross-sectional study including 2990 patients with MK, worse-presenting BCVA was associated with neighborhood-level risk factors including worse Area Deprivation Index, increased segregation (Theil H index), higher percentage of households with no car, and lower average number of cars per household.</p></sec><sec id="ab-eoi230034-3"><title>Meaning</title><p>Neighborhood-level factors could be considered in other patient populations when assessing presenting VA for patients with MK.</p></sec></abstract><abstract><sec id="ab-eoi230034-4"><title>Importance</title><p>Neighborhood-level social risk factors may contribute to health disparities in microbial keratitis (MK) disease presentation. Understanding neighborhood-level factors may identify areas for revised health policies to address inequities that impact eye health.</p></sec><sec id="ab-eoi230034-5"><title>Objective</title><p>To investigate if social risk factors were associated with presenting best-corrected visual acuity (BCVA) for patients with MK.</p></sec><sec id="ab-eoi230034-6"><title>Design, Setting, and Participants</title><p>This was a cross-sectional study of patients with a diagnosis of MK. Patients presenting to the University of Michigan with a diagnosis of MK between August 1, 2012, and February 28, 2021, were included in the study. Patient data were obtained from the University of Michigan electronic health record.</p></sec><sec id="ab-eoi230034-7"><title>Main Outcomes and Measures</title><p>Individual-level characteristics (age, self-reported sex, self-reported race and ethnicity), presenting log of the minimum angle of resolution (logMAR) BCVA, and neighborhood-level factors, including measures on deprivation, inequity, housing burden, and transportation at the census block group, were obtained. Univariate associations of presenting BCVA (&lt; 20/40 vs &#8805;20/40) with individual-level characteristics were assessed with 2-sample <italic toggle="yes">t</italic>, Wilcoxon, and &#967;<sup>2</sup> tests. Logistic regression was used to test associations of neighborhood-level characteristics with the probability of presenting BCVA worse than 20/40 after adjustment for patient demographics.</p></sec><sec id="ab-eoi230034-8"><title>Results</title><p>A total of 2990 patients with MK were identified and included in the study. Patients had a mean (SD) age of 48.6 (21.3) years, and 1723 were female (57.6%). Patients self-identified with the following race and ethnicity categories: 132 Asian (4.5%), 228 Black (7.8%), 99 Hispanic (3.5%), 2763 non-Hispanic (96.5%), 2463 White (84.4%), and 95 other (3.3%; included any race not previously listed). Presenting BCVA had a median (IQR) value of 0.40 (0.10-1.48) logMAR units (Snellen equivalent,&#8201;20/50 [20/25-20/600]), and 1508 of 2798 patients (53.9%) presented with BCVA worse than 20/40. Patients presenting with logMAR BCVA less than 20/40 were older than those who presented with 20/40 or higher (mean difference, 14.7 years; 95% CI, 13.3-16.1; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001). Furthermore, a larger percentage of male vs female sex patients presented with logMAR BCVA less than 20/40 (difference, 5.2%; 95% CI, 1.5-8.9; <italic toggle="yes">P</italic>&#8201;=&#8201;.04), as well as Black race (difference, 25.7%; 95% CI, 15.0%-36.5%;<italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001) and White race (difference, 22.6%; 95% CI, 13.9%-31.3%; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001) vs Asian race, and non-Hispanic vs Hispanic ethnicity (difference, 14.6%; 95% CI, 4.5%-24.8%; <italic toggle="yes">P</italic>&#8201;=&#8201;.04). After adjusting for age, self-reported sex, and self-reported race and ethnicity, worse Area Deprivation Index (odds ratio [OR],&#8201;1.30 per 10-unit increase; 95% CI,&#8201;1.25-1.35; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001), increased segregation (OR,&#8201;1.44 per 0.1-unit increase in Theil H index; 95% CI,&#8201;1.30-1.61; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001), higher percentage of households with no car (OR,&#8201;1.25 per 1 percentage point increase; 95% CI,&#8201;1.12-1.40; <italic toggle="yes">P</italic>&#8201;=&#8201;.001), and lower average number of cars per household (OR,&#8201;1.56 per 1 less car; 95% CI,&#8201;1.21-2.02; <italic toggle="yes">P</italic>&#8201;=&#8201;.003) were associated with increased odds of presenting BCVA worse than 20/40.</p></sec><sec id="ab-eoi230034-9"><title>Conclusion and Relevance</title><p>Findings of this cross-sectional study suggest that in a sample of patients with MK, patient characteristics and where they live were associated with disease severity at presentation. These findings may inform future research on social risk factors and patients with MK.</p></sec></abstract><funding-group><award-group><funding-source id="sp1">National Eye Institute</funding-source></award-group></funding-group><funding-group><award-group><funding-source id="sp2">Research to Prevent Blindness</funding-source></award-group></funding-group><funding-group><award-group><funding-source id="sp3">Michigan Institute for Clinical and Translational Research</funding-source></award-group></funding-group><funding-group><award-group><funding-source id="sp4">National Institutes of Health</funding-source></award-group></funding-group><funding-group><award-group><funding-source id="sp5">National Institute of General Medical Sciences</funding-source></award-group></funding-group><funding-group><award-group><funding-source id="sp6">National Institute of Diabetes and Digestive and Kidney Diseases</funding-source></award-group></funding-group><funding-group><award-group><funding-source id="sp7">National Institute of Biomedical Imaging and Bioengineering</funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>